The Food and Drug Administration is planning to expand its review of food additives beyond artificial dyes, targeting ...

The U.S. Food and Drug Administration plans to step up safety reviews on chemicals in foods, including one widely used as a ...

US FDA to convene expert panel for Capricor Therapeutics' DMD cell therapy Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside ...

The FDA is embracing natural colorants, with three approvals meant to replace synthetic dyes. Galdieria extract, butterfly ...

The U.S. Food and Drug Administration is reviewing the regulation and labeling of the abortion pill mifepristone following ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

WASHINGTON — Several food industry groups expressed a desire to work with the US Food and Drug Administration to phase out ...

OpenAI, known for developing ChatGPT, is reportedly in discussions with the US Food and Drug Administration (FDA) about 'AI for drug review.' The discussions between OpenAI and the FDA are ...

Amidst policy shifts and layoffs at the FDA, some biotechs are considering moving early clinical trials to Europe or ...

The move follows the FDA's announced plans to phase out synthetic dyes in the American food supply over the next several ...

Dr. David A. Kessler is a former Commissioner of the American Food and Drug Administration. He's written extensively on the food industry's role in engineering addictive foods, which contributes to ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...